Coherus BioSciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $10,254 | $7,599 | $54,144 | $70,774 |
Gross Profit | 5,843 | 4,946 | 20,286 | 50,033 |
EBITDA | -45,486 | -44,202 | -44,317 | -3,840 |
EBIT | -46,502 | -45,248 | -45,350 | -5,389 |
Net Income | 297,767 | -56,569 | -50,696 | -10,751 |
Net Change In Cash | 10,254 | 7,599 | 54,144 | 70,774 |
Free Cash Flow | -46,632 | -25,826 | 28,608 | -62,016 |
Cash | 216,893 | 82,411 | 125,987 | 97,690 |
Basic Shares | 116,077 | 115,857 | 115,418 | 115,210 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $266,960 | $257,244 | $211,042 | $326,551 |
Gross Profit | 149,407 | 98,252 | 140,959 | 268,960 |
EBITDA | 60,941 | -193,939 | -255,581 | -260,687 |
EBIT | 55,665 | -197,730 | -259,280 | -264,141 |
Net Income | 28,507 | -237,892 | -291,754 | -287,100 |
Net Change In Cash | 266,960 | 257,244 | 211,042 | 326,551 |
Cost of Revenue | -353,648 | -123,963 | ||
Free Cash Flow | -20,440 | -175,170 | -243,163 | -38,721 |
Cash | 125,987 | 102,891 | 63,547 | 417,195 |
Basic Shares | 114,830 | 94,162 | 77,630 | 75,449 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.35 |
2024-12-31 | -$0.28 |
